RECRUITING

The Severe Von Willebrand Disease (sVWD) Patient Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A web-based registry will be created by the sponsor, VWD Connect Foundation (VCF), to collect data on patients with severe Von Willebrand Disease (sVWD). Data will be self-reported by patients and/or collected by registry personnel, as appropriate. The purpose of the sVWD Patient Registry is to create a database of well-characterized (with respect to demographics, medical history, symptoms, laboratory and genetic data, etc.) patients with sVWD for participation in retrospective and prospective research.

Official Title

The Severe Von Willebrand Disease Patient Registry: A Longitudinal Natural History and Patient Outcomes Study

Quick Facts

Study Start:2021-12-10
Study Completion:2027-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05437536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have a clinical diagnosis of Von Willebrand Disease (VWD) with any Von Willebrand factor level(s) \< 20%
  2. * Provide informed consent by participant or legally authorized representative
  3. * Be willing and able to comply with study procedures and data collection
  4. * Reside in the United States
  1. * Have a clinical diagnosis of acquired VWD

Contacts and Locations

Study Contact

Christina Morgenthaler, MS, MBA
CONTACT
(279) 346-6202
morgenthaler@vwdregistry.org
Alice Arapshian
CONTACT
(279) 346-6202
arapshian@vwdregistry.org

Principal Investigator

Christopher Walsh, MD, PhD
PRINCIPAL_INVESTIGATOR
Mt. Sinai School of Medicine
Mrinal Gounder, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Christina Morgenthaler, MS, MBA
PRINCIPAL_INVESTIGATOR
VWD Connect Foundation
Alice Arapshian
PRINCIPAL_INVESTIGATOR
VWD Connect Foundation

Study Locations (Sites)

VWD Connect Foundation
Wellington, Florida, 33414
United States

Collaborators and Investigators

Sponsor: VWD Connect Foundation

  • Christopher Walsh, MD, PhD, PRINCIPAL_INVESTIGATOR, Mt. Sinai School of Medicine
  • Mrinal Gounder, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center
  • Christina Morgenthaler, MS, MBA, PRINCIPAL_INVESTIGATOR, VWD Connect Foundation
  • Alice Arapshian, PRINCIPAL_INVESTIGATOR, VWD Connect Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-10
Study Completion Date2027-01

Study Record Updates

Study Start Date2021-12-10
Study Completion Date2027-01

Terms related to this study

Keywords Provided by Researchers

  • VWD
  • Severe VWD
  • VWD Type 1 Severe
  • VWD Type 1C
  • VWD Type 2A
  • VWD Type 2B Severe
  • VWD Type 2M Severe
  • VWD Type 2N Severe
  • VWD Type 3
  • Von Willebrand Disease
  • VWB
  • Von Willebrands Disease

Additional Relevant MeSH Terms

  • VWD - Von Willebrand's Disease